# TRI-LO-LINYAH
> **ANDA090541** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2022-09-02
## Drug
- **FDA Application Number:** ANDA090541
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRI-LO-LINYAH
- **Generic name:** Norgestimate
- **Active ingredients:** NORGESTIMATE; ETHINYL ESTRADIOL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** NOVAST LABS
- **First approval:** 2022-09-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090541)
---
*MORVS · CC0 1.0*